Validating a new plasma cell labeling technique for targeted fluorescence in situ hybridization assay in patients diagnosed with multiple myeloma.
Fluorescence in situ hybridization (FISH) is a useful tool in diagnosing multiple myeloma (MM), a disease involving abnormal clones of plasma cells. In a standard FISH procedure, all types of cells within the sample are analyzed and scored. A new method, cytoplasmic immunoglobulin (cIg) FISH, has re...
Saved in:
Main Author: | Choo, Natasha Swee Lian. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Final Year Project |
Language: | English |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/44856 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Improving detection of chromosomal abnormalities in multiple myeloma using fluorescence in situ hybridization
by: Naw, Wah Wah
Published: (2010) -
Modifying risks assessment in patients with multiple myeloma with additional fluorescence in situ hybridization (FISH) probes.
by: Tan, Yu Min.
Published: (2010) -
The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: An analysis of the Singapore multiple myeloma study group
by: Tan, D., et al.
Published: (2016) -
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
by: Dimopoulos, M.A., et al.
Published: (2021) -
Targeting nf-κb signaling for multiple myeloma
by: Wong, A.H.-H., et al.
Published: (2021)